Features of diagnostics and treatment of malignant thyroid neoplasms-Reference-Cited by-同舟云学术

Features of diagnostics and treatment of malignant thyroid neoplasms

Published:2022-11-10 Issue:5 Volume:39 Page:41-47
ISSN:2687-1408
Container-title:Perm Medical Journal
language:
Short-container-title:Perm Medical Journal

Author:

Makarov I. V.^ORCID,Pismennyi I. V.^ORCID,Pismennyi V. I.^ORCID,Galkin R. A.^ORCID,Ruzanova A. A.^ORCID

Abstract

Objective. To analyze diagnostics and treatment of 50 patients operated for thyroid cancer (TC), to assess the information content of classification according to the TIRADS and BETHESDA systems in comparison with the final morphological study of the removed thyroid preparations. Materials and methods. Patients were divided into 3 groups. The first group 32 (64 %) patients with a verified thyroid cancer before surgery according to the results of fine needle aspiration puncture biopsy and a confirmed diagnosis after surgery. The second group, 4 (8 %) persons, included patients with a verified thyroid cancer before surgery, but a negative final morphological study. The third group, 14 (28 %) patients with an unverified thyroid cancer before surgery, but a confirmed diagnosis of thyroid cancer according to the results of a final morphological study. To compare the compliance of the TIRADS system with the BETHESDA system, the Kappa index was used. Results. The highest compliance, 100 %, was found between TIRADS 5 and BETHESDA 5, with a Kappa index of 1. Conclusions. Comparison of the results of preoperative and final morphological studies showed that the use of TIRADS and BETHESDA classifications is an informative method in diagnostics of thyroid cancer only in 48 % of cases.

Publisher

ECO-Vector LLC

Reference13 articles.

1. Molecular genetic studies in thyroid surgery. Tauride medico-biological Bulletin 2021; 24 (2): 118–126 (in Russian).

2. Beltsevich D.G., Vanushko V.E., Rumyantsev P.O., etc. Russian clinical guidelines for the diagnosis and treatment of highly differentiated thyroid cancer in adults. Endocrine surgery 2017; 1 (11): 6–27 (in Russian).

3. Mallika U.K., Harmera K., Mazzaferry E.L., Kendall-Taylor P. Tactics of thyroid gland treatment. Interdisciplinary concept 2022; 15: 175–203 (in Russian).

4. Reshetov I.V., Romanchishen A.F., Gostimsky A.V. Thyroid cancer. Moscow 2020; 55 (in Russian).

5. Kaprin A.D., Starinsky V.V. Malignant neoplasms in Russia in 2015 (morbidity and mortality). Moscow: P.A. Herzen Institute of Medical Research – Branch of the Federal State Budgetary Institution "NMIRC" of the Ministry of Health of Russia 2017; 33: 151 (in Russian).